Abiopharma

🔍 Lee Frank D. (Director)

Company: Bausch Health Companies Inc. (BHC)

Report Date: 2025-08-21

Detailed Transactions and Holdings:

• Sold 15,912 shares of Common Shares, No Par Value at $7.66 per share (Direct)
  Date: 2025-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 73,795.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares of common stock, no par value, of the Issuer sold in the open market to provide funds for estimated tax payments arising from a previously vested equity award granted to the Issuer's non-employee directors.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.66 to $7.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.